Αποτελέσματα Αναζήτησης
6 Φεβ 2018 · Drug Safety Update. Mycophenolate mofetil, mycophenolic acid: updated contraception advice for male patients. Mycophenolate mofetil and its active metabolite mycophenolic acid, both used to...
The MHRA products website allows you to find: The leaflets which are provided with medicines. The description of the medicinal product’s properties and how it can be used. Scientific reports...
View mycophenolate mofetil information, including dose, uses, side-effects, renal impairment, pregnancy, breast feeding, monitoring requirements and important safety information.
19 Δεκ 2019 · Pharmacy. Guidance. Find product information about medicines. Search for information about medicines including patient information leaflets (PILs), details on how the medicine can be used...
28 Νοε 2017 · The Medicines and Healthcare products Regulatory Agency (MHRA) has today announced Viagra Connect (containing sildenafil 50mg) will be formally classified from a prescription only medicine (POM)...
The recommended doses are: Alfuzosin. Immediate-release preparations (for benign prostatic hyperplasia [BPH]) — 2.5 mg three times daily, up to a maximum 10 mg daily. In elderly people, prescribe 2.5 mg twice daily initially, then adjust according to response up to a maximum of 10 mg daily.
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. Last updated on emc: 29 May 2024. View or print the patient leaflet as PDF.